Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Sunshine Biopharma's price to sales ratio was 0.0× on Oct 19, 2026, against 2.2× a year earlier. Over the last 4 years it ranged from 0.0× to 296.3×, with a median of 1.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.0× | −1.5 |
| 2025 | Dec 31, 2025 | 1.5× | −0.3 |
| 2024 | Dec 31, 2024 | 1.8× | −66.7 |
| 2023 | Dec 29, 2023 | 68.5× | – |